chr1-11998877-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3PP5
The NM_014874.4(MFN2):c.707C>T(p.Thr236Met) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T236T) has been classified as Uncertain significance.
Frequency
Consequence
NM_014874.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251478Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461554Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727118
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
Reported as heterozygous in an individual with Charcot-Marie-Tooth disease who was also heterozygous for a de novo variant in the GDAP1 gene; the variant in MFN2 was also present in the asymptomatic mother and the maternal grandfather with adult onset neuropathy (Kostera-Pruszczyk et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 32963807, 15549395, 25403865, 30373780, 30340945) -
MFN2: PM1, PM2, PS4:Moderate -
By the ACMG guideline 2015, this variant is classified as likely pathogenic (PM1, PM2, PP2, PP3) with multiple affected individuals reported. Our patient does not habour typical features of Charcot Marie Tooth disease or neuropathy. Rather, he presented with other neurological issues such as intellectual disability, behavioural problems and seizure. -
Charcot-Marie-Tooth disease type 2A2 Pathogenic:1
- -
Charcot-Marie-Tooth disease type 2 Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 236 of the MFN2 protein (p.Thr236Met). This variant is present in population databases (rs773159585, gnomAD 0.01%). This missense change has been observed in individuals with Charcot-Marie-Tooth disease (PMID: 15549395, 25403865, 33110000; Invitae). ClinVar contains an entry for this variant (Variation ID: 217165). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Distal muscle weakness;C1263857:Peripheral axonal neuropathy;C1836451:Distal lower limb amyotrophy Pathogenic:1
- -
Charcot-Marie-Tooth disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at